Smartwatches & Bands, Explained: The 2026 Field Guide
What smartwatches & bands covers, why it matters in 2026, and the numbers decision-makers should know.
If one theme defines digital health in 2026, it is the maturing of smartwatches & bands. Apple, Samsung, Fitbit and clinical-grade wrist sensing. This explainer sets out what the category actually covers, why it has moved to the center of wearables & rpm strategy, and the numbers every decision-maker should have at hand.
What it covers
Apple, Samsung, Fitbit and clinical-grade wrist sensing. In practice, that spans the vendors building the technology, the health systems and payers deploying it, and the regulators writing the rules around it. The category sits inside our broader Wearables & RPM coverage, and its daily developments stream into the live Smartwatches & Bands feed.
Why it matters in 2026
Consider the current numbers: global wearable shipments now exceed 136.5 million units per quarter.
Meanwhile, oura has sold 5.5 million rings, projects roughly $1.5 billion in 2026 revenue, and has filed confidentially for an IPO (our coverage).
Meanwhile, medicare remote patient monitoring spending has passed $500 million a year, and CMS has proposed consolidating seventeen RPM codes into four by 2027 (our coverage).
What to watch next
Three signals will tell you where smartwatches & bands goes from here: the reimbursement decisions now moving through CMS and commercial payers, the consolidation pattern as larger platforms absorb point solutions, and the evidence base - peer-reviewed results increasingly separate durable categories from demo-ware.
The bottom line
As with every wave before it, the technology is necessary but not sufficient - workflow, incentives, and trust decide the outcome. For the latest developments, follow our continuously updated Smartwatches & Bands topic page.